Search
  • Valis Bioscience

Christian Yavorsky (CSO) Co-Chairs the Rapid Acting Anti-Depressant Working Group at ISCTM

Valis is proud to announce that our Chief Scientific Officer and co-founder Dr. Christian Yavorsky has been selected as the co-chair of the working group for Rapid Acting Anti-Depressants (RADD) at ISCTM, the International Society for Clinical Trials Methodology.


Dr. Yavorsky, alongside Dr. Elizabeth Ballard, met with leading scientists at the annual meeting in Denmark (in partnership with ECNP) in order to lead discussion and support publication development for the working group. More about ISCTM and the working group can be found here:

https://isctm.org/meeting/2019-autumn-conference/

Recent Posts

See All

Valis attends ACNP Annual Meeting

Last week Valis CEO Ivan Goldensohn attended the American College of Neuropsychopharmacology meeting in Orlando, Florida. The ACNP Meeting (more info at https://acnp.org/) is an invite-only annual mee

Valis co-founder speaks at KRIYA Conference

Valis Co-founder and CSO Dr. Christian Yavorsky spoke last weekend at the Kriya Conference in Northern California. Alongside Dr. Kelley O'Donnell, a researcher and practitioner at NYU, Dr. Yavorsky pr

Contact VALIS
ContaCT SUPPORT:
HELP@VALISBIOSCIENCE.com

Valis has locations in San Francisco, CA,  Berkeley CA, and New York, NY.

Valis Biosciences, Inc.

2111 San Pablo Ave

PO Box 2054

Berkeley California, 94702

  • LinkedIn Social Icon
  • Black Facebook Icon
  • Black Twitter Icon
General Inquiries:

© 2020 @ Valis Biosciences Inc. All rights reserved.